Description     Claims     Drawing  

JP2014065748A   [0007] 
JP2010083863A   [0007] 
JP2014140982A   [0063] 

Activated development of antibody medicines related to PD-1 (in Japanese)   [0008] 
Marked and sustained tumor response with combination of ipilimumab and anti-PD-1 antibody medicine nivolumab in half of advanced malignant melanoma (in Japanese)   [0008] 
The New England Journal of Medicine   [0008] 
PLOS One   [0008] 
ANTIBODY PRODUCTION ESSENTIAL TECHNIQUES   [0023] 
Nature   [0025] 
Immunology Today   [0025] 
MONOCLONAL ANTIBODIES AND CANCER THERAPY   [0025] 
J Vet Med Sci   [0044]